Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects

Psychoactive synthetic adulterants in tablets sold as "MDMA" after the COVID-19 pandemic: implication for central effects Psychoactive synthetic adulterants in tablets sold as "MDMA" after the COVID-19 pandemic: implication for central effects Abbreviations AB-PINACA, N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide; 2C-B, 4-bromo-2,5-dimethoxyphenethylamine; 2-Cl-4,5-MDMA, 2-chloro-4,5-methylenedioxymethamphetamine; 25I-NBOMe, 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine; 3-CMC, 3-chloromethcathinone; 4F-MDMB-BINACA, methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate; 3-FEA, 3-fluoroethamphetamine;